Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The EURODIAB IDDM Complications Study involved the examination of 3250 randomly selected insulin-dependent diabetic patients, from 31 centres in 16 European countries. Part of the examination included an assessment of neurological function including neuropathic symptoms and physical signs, vibration perception threshold, tests of autonomic function and the prevalence of impotence. The prevalence of diabetic neuropathy across Europe was 28% with no significant geographical differences. Significant correlations were observed between the presence of diabetic peripheral neuropathy with age (p < 0.05), duration of diabetes (p < 0.001), quality of metabolic control (p < 0.001), height (p < 0.01), the presence of background or proliferative diabetic retinopathy (p < 0.01), cigarette smoking (p < 0.001), high-density lipoprotein cholesterol (p < 0.001) and the presence of cardiovascular disease (p < 0.05), thus confirming previous associations. New associations have been identified from this study - namely with elevated diastolic blood pressure (p < 0.05), the presence of severe ketoacidosis (p < 0.001), an increase in the levels of fasting triglyceride (p < 0.001), and the presence of microalbuminuria (p < 0.01). All the data were adjusted for age, duration of diabetes and HbA1c. Although alcohol intake correlated with absence of leg reflexes and autonomic dysfunction, there was no overall association of alcohol consumption and neuropathy. The reported problems of impotence were extremely variable between centres, suggesting many cultural and attitudinal differences in the collection of such information in different European countries. In conclusion, this study has identified previously known and new potential risk factors for the development of diabetic peripheral neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, even in more contemporary cohorts with recent-onset T2D prevalence rates of up to 25% have been observed,545,546 including in youth417,612–615 or at different degrees of glucose intolerance.616”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [545]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Young, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434 · cited 1×
“1) the presence of one or more symptoms; 2) absence of two or more ankle or knee reflexes; 3) vibration perception threshold which was abnormal relating to age-related measures [12] and 4) abnormal autonomic function assessed using Ewing’s definitons [13] of postural hypotension with a fall in systolic blood pressure…”
MethodPirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.168 · Cited by 1,290
Maser, R. E., Steenkiste, A. R., Dorman, J. S., Nielsen, V. K., Bass, E. B., Manjoo, Q., Drash, A. L., Becker, D. J., Kuller, L. H., Greene, D. A., et al. (1989) · Diabetes · doi:10.2337/diab.38.11.1456 · Cited by 408
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.4.252 · Cited by 358
Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
Stephenson, J., Fuller, J. H., & EUROBIAB IDDM Complications Study Group (1994) · Diabetologia · doi:10.1007/bf00398055 · Cited by 345
Self-citationReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
(1988) · Diabetes · doi:10.2337/diab.37.7.1000 · Cited by 308
Malik, R. A., Newrick, P. G., Sharma, A. K., Jennings, A., Ah-See, A. K., Mayhew, T. M., Jakubowski, J., Boulton, A. J. M., & Ward, J. D. (1989) · Diabetologia · doi:10.1007/bf00505180 · Cited by 294
Self-citationSENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
FRANKLIN, G. M., KAHN, L. B., BAXTER, J., MARSHALL, J. A., & HAMMAN, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Cited by
Items 301–400 of 693
Liu, M., Gao, Y., Chen, D., Lin, S., Wang, C., Chen, L., & Ran, X. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13515 · Cited by 24
Perimenis, P., Gyftopoulos, K., Athanasopoulos, A., & Barbalias, G. A. (2001) · European Urology · doi:10.1159/000049806 · Cited by 21
Sexual dysfunction in patients with peripheral nervous system lesions
Podnar, S., & Vodušek, D. B. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63247-0.00011-0 · Cited by 21
Impact of Exercise Training in Patients with Diabetic Peripheral Neuropathy: An Umbrella Review
Gracia‐Sánchez, A., López‐Pineda, A., Nouni-García, R., Zúnica‐García, S., Chicharro‐Luna, E., & Gil-Guillén, V. F. (2025) · Sports Medicine - Open · doi:10.1186/s40798-025-00863-4 · Cited by 28
Urbano, F., Farella, I., Brunetti, G., & Faienza, M. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511980 · Cited by 25
Kobayashi, Y., Suzuki, R., Yasukawa, K., Oba, K., Yamauchi, T., Yatomi, Y., & Kadowaki, T. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100032 · Cited by 22
Glycated hemoglobin and subsequent risk of microvascular and macrovascular complications
Samanta, S. (2020) · Indian Journal of Medical Sciences · doi:10.25259/ijms_16_2020 · Cited by 24
Peripheral Insensate Neuropathy- Is Height a Risk Factor?
Kote, G. S. S. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/5140.2751 · Cited by 20
“Many factors have been associated with neuropathy, like age, sex, race, glycaemic control, nutrition, toxin exposure, drugs, alcohol, etc [1,3,4].”
BackgroundResultInfluentialGlycated albumin indicates peripheral diabetic neuropathy
Wang, N., Guo, C., Han, P., & Li, T. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0900-y · Cited by 20
“Research has also shown that HbA1c is a strong predictor of diabetic neuropathy [23–26], but, until now, there has been no investigation of the relationship between GA and diabetic neuropathy.”
BackgroundNonproliferative Diabetic Retinopathy
Chew, E. Y., & Ferris, F. L. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02598-0.50073-2 · Cited by 25
Alò, K. M., & Zidan, A. (2000) · Neuromodulation Technology at the Neural Interface · doi:10.1046/j.1525-1403.2000.00201.x · Cited by 20
Shao, Z., Wang, Z., Bi, S., & Zhang, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1107830 · Cited by 19
Development of a Novel Customized Insole for Effective Pressure Offloading in Diabetic Patients
Bose, D., Singh, G., Gupta, S. B., & Chanda, A. (2024) · Prosthesis · doi:10.3390/prosthesis6020026 · Cited by 60
Diabetic neuropathy in children
Mah, J. K., & Pacaud, D. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00010-2 · Cited by 20
Neuropatía diabética periférica
Gadea, N. H. (2000) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(00)70189-2 · Cited by 19
Association of chronic diabetes and hypertension in sural nerve morphometry: an experimental study
Sanada, L. S., Tavares, M. R., Sato, K., Ferreira, R. D. S., Neubern, M. C. M., Castania, J. A., Salgado, H. C., & Fazan, V. P. S. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0005-8 · Cited by 19
Diabetic neuropathy: achieving best practice
Tesfaye, S. H. (2003) · The British Journal of Diabetes · doi:10.1177/14746514030030020601 · Cited by 19
Self-citationThe Effects of C‐peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy in the BB/Wor‐rat
Sima, A. A. F., Zhang, W., Li, Z.-G., & Kamiya, H. (2008) · Journal of Diabetes Research · doi:10.1155/2008/230458 · Cited by 21
Bakker, S. F., Tushuizen, M. E., Flier, B., Bontkes, H. J., Mulder, C. J. J., & Şimşek, S. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0166-0 · Cited by 20
“Microvascular complications Intensive insulin therapy to normalize blood glucose levels effectively delays the onset and slows the progression of microvascular complications including diabetic retinopathy, nephropathy and neuropathy in T1DM patients [55–57].”
BackgroundFoam dressings for healing diabetic foot ulcers
Dumville, J. C., Deshpande, S., O’Meara, S., & Speak, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009111.pub2 · Cited by 32
Foam dressings for healing diabetic foot ulcers
Dumville, J. C., Deshpande, S., O’Meara, S., & Speak, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009111 · Cited by 32
Rajguru, P., Kolber, M. J., Garcia, A. N., Smith, M. T., Patel, C. K., & Hanney, W. J. (2015) · American Journal of Lifestyle Medicine · doi:10.1177/1559827614522580 · Cited by 18
Prevalence and risk factors of diabetes foot ulcers in Kano, northwestern Nigeria
Aliyu, R., Gezawa, I., Uloko, A. E., & Ramalan, M. A. (2023) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-023-00155-4 · Cited by 18
Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy
Liu, C., Wu, T., & Ren, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1268619 · Cited by 22
Simple tests to screen for diabetic peripheral neuropathy
Yang, Z., Zhang, Y., Chen, R., Huang, Y., Ji, L., Sun, F., Hong, T., & Zhan, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010975 · Cited by 21
RetractedAbougalambou, S. S. I., Hassali, M. A., Sulaiman, S. A. S., & Abougalambou, A. S. (2011) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000115 · Cited by 22
A brief review on the pathogenesis of human diabetic neuropathy: Observations and Postulations
Rajbhandari, S., & Piya, M. K. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497581 · Cited by 18
“11 Similarly, associations between DN and serum cholesterol, triglycerides and lipoproteins have been reported by different workers to be statistically significant.(3,15,16,17) Mitchell et al 18 found that the risk of developing DN was more than three times in type 1 subjects who smoked than non smokers, but smoking w…”
BackgroundInfluentialChristensen, M. M. B., Hommel, E. E., Jørgensen, M. E., von Scholten, B. J., Fleischer, J., & Hansen, C. S. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0249 · Cited by 20
Prevention and Management of Chronic Wounds
Andrews, K. L., Derby, K. M., Jacobson, T. M., Sievers, B. A., & Kiemele, L. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-62539-5.00024-2 · Cited by 20
Challenges in Diabetic Micro-Complication Management: Focus on Diabetic Neuropathy
Ansari, P., Hannan, J. M. A., Azam, S., & Jakaria, M. (2021) · International Journal of Translational Medicine · doi:10.3390/ijtm1030013 · Cited by 22
“Interestingly, almost 50% of individuals with diabetes developing lifetime risk diabetic neuropathy [24,25]; it is one of the least studied diabetic complications due to its direct and accurate measurement difficulty.”
BackgroundWang, X., Chen, J., Liu, X., Gao, F., Zhao, H., Han, D., Jing, X., Liu, Y., Cui, Z., Li, C., et al. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0327-7 · Cited by 17
“Diabetic peripheral neuropathy was diagnosed if abnormalities were found in two or more of the described criteria: (1) the presence of one or more symptoms; (2) the absence of two or more ankle or knee reflexes; (3) abnormal vibration perception threshold related to age-related measures; (4) abnormal autonomic functio…”
BackgroundShivaprasad, C., Amit, G., Kolly, A., Rakesh, B., Anupam, B., & Aiswarya, Y. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.004 · Cited by 17
The Epidemiology of Diabetic Neuropathy
Hansen, C. S., Määttä, L. L., Andersen, S. T., & Charles, M. H. (2023) · Contemporary Diabetes · doi:10.1007/978-3-031-15613-7_2 · Cited by 17
Zhang, H., Yang, S., Wang, H., Farooqui, H. F. M., Zhu, W., Niu, T., Zhang, Z., Chen, Y., Huang, L., Zhang, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78828-y · Cited by 17
Purohit, S. B., Tran, P. M. H., Tran, L. K. H., Satter, K. B., He, M., Zhi, W., Bai, S., Hopkins, D., Gardiner, M., Wakade, C. G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654233 · Cited by 20
Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN)
Sharma, S., & Rayman, G. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1165505 · Cited by 20
Abougalambou, S. S. I., Mohamed, M., Sulaiman, S. A. S., Abougalambou, A. S., & Hassali, M. A. (2010) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2010.08.001 · Cited by 17
Latent autoimmune diabetes of adulthood ( LADA ) is associated with small fibre neuropathy
Alam, U., Jeziorska, M., Petropoulos, I. N., Pritchard, N., Edwards, K. P., Dehghani, C., Srinivasan, S., Asghar, O., Ferdousi, M., Ponirakis, G., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13888 · Cited by 18
Hansen, C. S., Lundby-Christiansen, L., Tarnow, L., Gluud, C. N., Hedetoft, C., Thorsteinsson, B., Hemmingsen, B., Wiinberg, N., Sneppen, S. B., Lund, S. S., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01131-3 · Cited by 21
“Prevalence rates of DPN have been reported to vary from 10 to 41% [4, 5].”
BackgroundBurger, A. J., Hamer, A. W., Weinrauch, L. A., & D’Elia, J. A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00070-8 · Cited by 17
A predisposição genética para o desenvolvimento da microangiopatia no DM1
Corrêa‐Giannella, M. L., & Vieira, S. M. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200026 · Cited by 17
Treatment-Induced Neuropathy in Diabetes (TIND)—Developing a Disease Model in Type 1 Diabetic Rats
Baum, P., Koj, S., Klöting, N., Blüher, M., Claßen, J., Paeschke, S., Gericke, M. T., Toyka, K. V., Nowicki, M., & Kosacka, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041571 · Cited by 18
Greco, C., Nascimbeni, F., Carubbi, F., Andreoné, P., Simoni, M., & Santi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194466 · Cited by 20
“DPN occurs in at least 20% of people with type 1 DM (T1DM) after 20 years of disease duration, as suggested by large observational cohorts [2,3] and the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study [4,5].”
BackgroundPrediction of Diabetic Sensorimotor Polyneuropathy Using Machine Learning Techniques
Shin, D. Y., Lee, B., Yoo, W. S., Park, J. W., & Hyun, J. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194576 · Cited by 18
“DSPN is significantly correlated with poor glucose control [18,19], longer duration of diabetes, poor metabolic management, smoking and the presence of cardiovascular disease, and DSPN severity is correlated with hypertension, dyslipidemia, microalbuminuria, alcohol consumption, and body mass index [20,21].”
BackgroundAlpha adrenoceptor agonist-induced microcirculatory oscillations are reduced in diabetic neuropathy
Schmiedel, O., Nurmikko, T. J., Schroeter, M. L., Whitaker, R., & Harvey, J. N. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.04.004 · Cited by 16
Risk factors for diabetic neuropathy and foot ulceration
Adler, A. (2001) · Current Diabetes Reports · doi:10.1007/s11892-001-0035-5 · Cited by 18
Lower limb nerve impairment in diabetic patients: multiperspective assessment
Padua, L., Saponara, C., Ghirlanda, G., Padua, L., Aprile, I. G., Caliandro, P., & Tonali, P. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00342.x · Cited by 16
“To evaluate the clinical-neurophysiological and metabolic assessment, a previously reported protocol (Tesfaye et al., 1996) was used.”
MethodDiabetic Peripheral and Autonomic Neuropathy
Feldman, E. L., Stevens, M. J., & Russell, J. W. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-310-1_24 · Cited by 18
Hydrogel dressings for healing diabetic foot ulcers
Dumville, J. C., O’Meara, S., Deshpande, S., & Speak, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009101.pub2 · Cited by 32
Drugs for the treatment of peripheral neuropathies
Marmiroli, P., & Cavaletti, G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1120719 · Cited by 15
“increase the probability to develop peripheral nerve damage.[54] Diabetic neuropathy can present with different clinical pictures, distal symmetric sensorimotor”
BackgroundJiang, D.-Q., Xu, L.-C., Jiang, L.-L., Li, M., & Wang, Y. (2018) · Medicine · doi:10.1097/md.0000000000011390 · Cited by 16
“The patients with DPN mainly accepted comprehensive therapies on the basis of intensive blood glucose control, including vascular dilation, microcirculation improvement, antioxidation, and trophic regulation of nerve cells in the peripheral nervous system.([1,4,5]) Fasudil (F) can improve microcirculatory disturbance…”
BackgroundEvans, M. C., Wade, C., Hohenschurz‐Schmidt, D., Lally, P., Ugwudike, A., Shah, K., Bangerter, N. K., Sharp, D. J., & Rice, A. S. C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.727311 · Cited by 16
Control of risk factors among people with diagnosed diabetes, by lower extremity disease status.
Dorsey, R. R., Eberhardt, M. S., Gregg, E. W., & Geiss, L. S. (2009) · Preventing Chronic Disease · Cited by 26
Singhal, K., & Sandhir, R. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23478 · Cited by 16
“Diabetes leads to microvascular and macrovascular complications that affect the kidneys, retina, and peripheral nervous system (Biessels et al., 1994; Tesfaye et al., 1996).”
BackgroundRoberts, A. J. C., Law, J. R., Suerken, C. K., Reboussin, B. A., Lawrence, J. M., Taplin, C. E., Mayer‐Davis, E. J., & Pihoker, C. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107980 · Cited by 17
Hidasi, E., Káplár, M., Diószeghy, P., Bereczki, D., Csiba, L., Limburg, M., & Fülesdi, B. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00181-7 · Cited by 15
Lin, I., Wang, Y., Lin, C., Chang, Y., Lee, S., & Wang, I. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12746 · Cited by 14
“(Tesfaye et al.1996, 2005; Girach et al.2006).”
BackgroundResultOmaña, H., Madou, E., Montero‐Odasso, M., Payne, M. W. C., Viana, R., & Hunter, S. W. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816999201001203652 · Cited by 17
Nerve conduction in children suffering Insulin Dependent Diabetes Mellitus
Çenesiz, F., Tur, B. S., Teziç, T., & Gürer, Y. (2003) · The Indian Journal of Pediatrics · doi:10.1007/bf02723816 · Cited by 14
Inzucchi, S. E., & Majumdar, S. K. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.018 · Cited by 15
Foot temperature in diabetic polyneuropathy: innocent bystander or unrecognized accomplice?
Rutkove, S. B., Chapman, K. M., Acosta, J., & Larrabee, J. E. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01486.x · Cited by 14
Anderson, S. G., Malipatil, N. S., Roberts, H., Dunn, G., & Heald, A. H. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.08.004 · Cited by 13
Trento, M., Panero, F., Porta, M., Gruden, G., Barutta, F., Cerutti, F., Gambino, R., Perotto, M., Perin, P. C., & Bruno, G. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.01.004 · Cited by 13
“Microvascular complications were defined by standardized procedures, according to the EURODIAB protocol (15).”
Prevalence of Diabetic Retinopathy among Type - 2 Diabetes Patients in Pakistan - Vision Registry
Sohail, M. R. (2014) · Pakistan Journal of Ophthalmology · doi:10.36351/pjo.v30i4.201 · Cited by 26
Jiang, D.-Q., Zhao, S.-H., Li, M., Jiang, L.-L., Wang, Y., & Wang, Y. (2018) · Medicine · doi:10.1097/md.0000000000013020 · Cited by 13
“Currently, DPN is believed to be closely related to various factors, including genetic predisposition, glucose toxicity, abnormal aldose reductase activity, oxidative stress.([5,35]) Besides that, factors such as diabetic microangiopathy-induced hypoxic-ischemic neuronal death and altered hemodynamics, as well as diso…”
BackgroundAmani, Y. W. (2014) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · Cited by 13
Unmar, Y., Zafar, M. I., & Gao, F. (2017) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-017-1737-5 · Cited by 15
Chinese herbal medicine for diabetic peripheral neuropathy
Chen, W., Zhang⋆, Y., & Liu, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007796.pub2 · Cited by 17
Hydrocolloid dressings for healing diabetic foot ulcers
Dumville, J. C., Deshpande, S., O’Meara, S., & Speak, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009099 · Cited by 13
Lin, K., Wu, Y., Liu, S., Huang, J., Chen, G., & Zeng, Q. (2022) · PeerJ · doi:10.7717/peerj.13089 · Cited by 13
“This is consistent with previous studies (Tesfaye et al., 1996).”
Tabata, H. (2000) · Drug and Chemical Toxicology · doi:10.1081/dct-100100130 · Cited by 12
“Additionally, since many diabetic patients are unaware of their hypoglycemia, it may be a risk factor in developing diabetic neuropathy.(6) There are many reports of insulin-induced hypoglycemic damage of peripheral nerves in rats.”
BackgroundMateen, S., Thomas, M. A., Jappar, A., Wu, S., Meyr, A. J., & Siddiqui, N. A. (2023) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2023.03.004 · Cited by 12
Anita, H. C., Manoj, A., Arunagirinathan, N., Rameshkumar, M. R., Revathi, K., Selvam, R., Kannan, T., Darwish, N., Farraj, D. A. A., & Abdelgawwad, M. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102891 · Cited by 14
Vila, J., Mur, T., Costa, B., Barrio, F., López-Moya, C., Sagarra-Alamo, R., García-Barco, M., Vizcaíno, J., Bonaventura, I., Ortiz, N., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050598 · Cited by 12
“Moreover, some patients may develop hypoesthesia, which may lead to severe foot lesions [7].”
Diagnosis of diabetic polyneuropathy in primary care
Khramilin, V. N., Strokov, I. A., Давыдов, О. С., & Churyukanov, M. V. (2021) · Russian Journal of Pain · doi:10.17116/pain20211902147 · Cited by 15
Andrén‐Sandberg, Å., & Hardt, P. D. (2005) · PubMed · Cited by 18
Oxidative Stress and Diabetic Neuropathy
Park, Y. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-405885-9.00001-2 · Cited by 12
Rigiscan Evaluation of Specific Nervous Impairment in Patients With Diabetes and Erectile Disorders
Bax, G., Marin, N., Piarulli, F., Lamonica, M., Bellio, F., & Fedele, D. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1159 · Cited by 12
Multiperspective Assessment of Peripheral Nerve Involvement in Diabetic Patients
Padua, L., Aprile, I. G., Saponara, C., Padua, L., Ghirlanda, G., Pauri, F., D’Amico, P., & Tonali, P. (2001) · European Neurology · doi:10.1159/000052132 · Cited by 12
Kamiya, H., Himeno, T., Watarai, A., Baba, M., Nishimura, R., Tajima, N., & Nakamura, J. (2024) · Diabetology International · doi:10.1007/s13340-023-00678-2 · Cited by 11
“Of these factors, age, history of diabetes, body weight, HbA1c, history of cerebral vascular disease, and systolic blood pressure are consistent with previous reports for type 1 diabetes [19].”
Kaewput, W., Thongprayoon, C., Rangsin, R., Mao, M. A., Satirapoj, B., & Cheungpasitporn, W. (2018) · Hospital Practice · doi:10.1080/21548331.2019.1549916 · Cited by 11
“Several previous studies demonstrated an association between peripheral neuropathy and albuminuria in diabetic patients [8,38,39].”
BackgroundPoint Prevalence of Peripheral Neuropathy in Children and Adolescents with Type 1 Diabetes Mellitus
Singh, D. P., Singh, P., Sharma, S., Aneja, S., & Seth, A. (2021) · The Indian Journal of Pediatrics · doi:10.1007/s12098-021-03742-4 · Cited by 12
“Longer duration of diabetes and poor glycemic control are the major determinants of DPN [13].”
BackgroundMateen, S., Thomas, M. A., & Siddiqui, N. A. (2023) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2023.08.001 · Cited by 11
Kamenov, Z. A., & Traykov, L. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_14 · Cited by 12
Association between Pulse Wave Velocity and Nerve Conduction Study in Diabetic Patients
Suh, B. C., Chung, P., Moon, H., Kim, Y. B., Yoon, W. T., Shim, D. S., & Kim, S. B. (2010) · European Neurology · doi:10.1159/000319605 · Cited by 11
Landgraf, R., Kellerer, M., Aberle, J., Fach, E.-M., Gallwitz, B., Hamann, A., Joost, H., Klein, H., Müller‐Wieland, D., Nauck, M. A., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0598-0475 · Cited by 18
The role of the ITLN1 gene rs2274907 polymorphism in diabetic foot patients
Mrozikiewicz‐Rakowska, B., Sobczyk‐Kopcioł, A., Szymański, K., Nehring, P., Szatkowski, P., Bartkowiak-Wieczorek, J., Bogacz, A., Aniszczuk, A., Drygas, W., Płoski, R., et al. (2017) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4008 · Cited by 11
Chromosomal Aberrations and Exon 1 Mutation in the AKR1B1 Gene in Patients with Diabetic Neuropathy.
Saraswathy, R., Anand, S., Kunnumpurath, S., Kurian, R. J., Kaye, A. D., & Vadivelu, N. (2014) · Europe PMC (PubMed Central) · Cited by 11
The Epidemiology of Diabetic Neuropathy
Wheeler, S., Singh, N. K., & Boyko, E. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-311-0_2 · Cited by 12
Follow-up of advanced diabetic neuropathy
Kr�mer, H. H., Rolke, R., Hecht, M. J., Bickel, A., & Birklein, F. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0645-y · Cited by 11
New treatments for diabetic neuropathy: Symptomatic treatments
Krishnan, S. T. M., & Rayman, G. A. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0008-y · Cited by 11
“Diabetic neuropathy is common, with up to 60% of people with diabetes reported to be affected and with as much as half of these experiencing pain [1–5].”
BackgroundTsilingiris, D., Schimpfle, L., von Rauchhaupt, E., Sulaj, A., Seebauer, L., Bartl, H., Herzig, S., Szendroedi, J., Kopf, S., & Κender, Ζ. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad248 · Cited by 12
Mizrak, H. I., Hansen, T. W., Rossing, P. R., Curovic, V. R., Vistisen, D., Amadid, H., & Hansen, C. S. (2023) · Diabetes Care · doi:10.2337/dc23-0312 · Cited by 11
Diabetic neuropathy and the sensory apparatus “meissner corpuscle and merkel cells”
Alsunousi, S. I. A., & Marrif, H. I. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00079 · Cited by 10
Jardim, A. D. I., & Leal, A. M. O. (2009) · Physis Revista de Saúde Coletiva · doi:10.1590/s0103-73312009000200009 · Cited by 30
Elissen, A., Adams, J., Spreeuwenberg, M. D., Duimel-Peeters, I. G. P., Spreeuwenberg, C., Linden, A., & Vrijhoef, H. J. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-40 · Cited by 10
“Where possible, covariates were analyzed both as continuous and as categorical variables, with categories based on scientific literature (age [31] and disease duration [32]), median values (measurement frequency and length of follow-up), or, in the case of baseline health status, on the target values for clinical para…”
BackgroundMs, A., Hi, A., & Juwita, S. (2012) · International journal of collaborative research on internal medicine & public health · Cited by 16
Does peripheral neuropathy invariably accompany nephropathy in type 1 diabetes mellitus?
Shaw, J. E., Gokal, R., Hollis, S., & Boulton, A. J. M. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(97)00122-8 · Cited by 10
Measurement of somatic neuropathy for clinical practice and clinical trials
Scott, V. A. L., & Tesfaye, S. H. (2001) · Current Diabetes Reports · doi:10.1007/s11892-001-0036-4 · Cited by 10
Self-citationAlpha-lipoic acid in the treatment of diabetic polyneuropathy
Chukanova, E. I., & Сергеевна, Ч. А. (2018) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201811811103-109 · Cited by 10
Metadata
- Authors
- Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D.
- Affiliations
- Royal Liverpool University Hospital (GB)
- University College London (GB)
- Royal Hallamshire Hospital (GB)
- München Klinik Schwabing (DE)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Diabetologia
- Published
- 1996-10-23
- Volume
- 39
- Issue
- 11
- Pages
- 1377-1384
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2049568996
- Cited by
- 695
- References
- 30
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 17 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 32 · 2019: 30 · 2018: 35 · 2017: 23 · 2016: 27 · 2015: 36 · 2014: 41 · 2013: 36 · 2012: 27
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Pfizer
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, prevalence, type 1 diabetes, glycemic control, risk factors, diabetes duration, diabetic retinopathy, smoking, HDL cholesterol, cardiovascular disease, diastolic blood pressure, ketoacidosis, fasting triglycerides, microalbuminuria, autonomic dysfunction, erectile dysfunction, alcohol consumption
- MeSH terms
- Adolescent, Adult, Blood Pressure, Body Constitution, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Diabetic Retinopathy, Europe, Female, Humans, Hypoglycemia, Lipids, Male, Middle Aged, Peripheral Nervous System Diseases, Regression Analysis, Risk Factors, Smoking, Body Mass Index, Prevalence, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.